EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Alessio Bruni iD, Vieri Scotti, Maria Alessia Zerella iD, Federica Bertolini, Jessica Imbrescia, Emanuela Olmetto, Chiara Bennati iD, Francesco Cuccia iD, Marianna Miele, Niccolò Giaj-Levra, Marcello Tiseo iD, Patrizia Ciammella und 8 weitere

Current Oncology · 2024

DOI: 10.3390/curroncol31110501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Alessio Bruni und 19 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Immunotherapy. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extensive-stage small-cell lung cancer (ES-SCLC) treatment has recently been revolutionized by the advent of immune checkpoint inhibitors. This survey was conducted to evaluate the current pattern of care among Italian clinicians, in particular about the integration with radiation therapy (RT).

Methods

In June 2023, 225 Italian cancer care professionals were invited to complete a 21-question web-based survey about ES-SCLC management through personal contacts and the Italian Association for Radiotherapy and Clinical Oncology (AIRO) network.

Results

We received 90 responses; the majority were radiation oncologists (89%) with more than 10 years of experience (51%). The preferred management of ES-SCLC in patients with a good performance status was concomitant chemo-immunotherapy (84%). Almost all respondents recommended prophylactic cranial irradiation (PCI) (85%), taking into account age and thoracic response; PCI was performed mainly between the end of chemotherapy and before starting immunotherapy (37%), with a three-dimensional conformal technique (46%). Furthermore, 83% of respondents choose to deliver thoracic RT in the case of both an intrathoracic and extrathoracic response, with an RT schedule of 30 Gy/10 fractions. Stereotactic RT is increasingly being used in oligoprogressions.

Conclusions

Our analysis showed the variability of real-world management of ES-SCLC. Future clinical trials and developments are needed to improve the multidisciplinary treatment of these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsImmunotherapyHumansItalySurveys and QuestionnairesRadiation OncologyMedical OncologyPractice Patterns, Physicians'Cranial Irradiation

Stichwörter der Autor:innen

national Italian surveyradiation therapysmall-cell lung cancer

Autor:innen und Institutionen

  • Radiation Oncology Unit, Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy.
  • Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, 50134 Firenze, Italy.
  • Division of Radiotherapy, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, 20141 Milano, Italy.
  • Division of Oncology, Department of Oncology and Hematology, Modena University Hospital, 41124 Modena, Italy.
  • Department of Onco-Hematology, AUSL della Romagna, 48121 Ravenna, Italy.
  • Radiotherapy Unit, ARNAS Civico Hospital, 90145 Palermo, Italy.

ORCID-Profile: Alessio Bruni, Maria Alessia Zerella, Chiara Bennati, Francesco Cuccia, Marcello Tiseo, Stefano Vagge, Antonio Pontoriero, Ruggero Spoto, Emanuele Alì, Paolo Borghetti

Zitieren

APA

Bruni, A., Scotti, V., Zerella, M. A., Bertolini, F., Imbrescia, J., Olmetto, E., Bennati, C., Cuccia, F., Miele, M., Giaj-Levra, N., Tiseo, M., Ciammella, P., Vagge, S., Galaverni, M., Pontoriero, A., Badellino, S., Spoto, R., Alì, E., Borghetti, P., & Associazione Italiana Radioterapia Oncologica (AIRO) (2024). Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Current Oncology. https://doi.org/10.3390/curroncol31110501

Vancouver

Bruni A, Scotti V, Zerella MA, Bertolini F, Imbrescia J, Olmetto E, et al. Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Current Oncology. 2024. doi:10.3390/curroncol31110501

BibTeX
@article{Bruni2024,
  author = {Bruni, Alessio and Scotti, Vieri and Zerella, Maria Alessia and Bertolini, Federica and Imbrescia, Jessica and Olmetto, Emanuela and Bennati, Chiara and Cuccia, Francesco and Miele, Marianna and Giaj-Levra, Niccolò and Tiseo, Marcello and Ciammella, Patrizia and Vagge, Stefano and Galaverni, Marco and Pontoriero, Antonio and Badellino, Serena and Spoto, Ruggero and Alì, Emanuele and Borghetti, Paolo and Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Radioterapia Oncologica (AIRO)},
  title = {Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31110501}
}
Kostenlos starten →